Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Modal Longevity Protocol Integrating Lifestyle, Supplements, and Autologous Pro-Regenerative Cell-Conditioned Media: A Pilot Study

NCT07322224 is registered in ClinicalTrials.gov with BlueBird Age Reversal SA as lead sponsor.

NCT NCT07322224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07322224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Modal Longevity Protocol Integrating Lifestyle, Supplements, and Autologous Pro-Regenerative Cell-Conditioned Media: A Pilot Study
Lead sponsor
BlueBird Age Reversal SA
Phase
Not applicable
Overall status
Completed
Start date
August 5, 2024
Completion date
March 20, 2025
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biological aging, healthy aging, longevity